The report provides a detailed analysis essential for establishing an Esomeprazole production plant. It encompasses all critical aspects necessary for Esomeprazole production, including the cost of Esomeprazole production, Esomeprazole plant cost, Esomeprazole production costs, and the overall Esomeprazole production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating an Esomeprazole production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Esomeprazole is a proton pump inhibitor (PPI) that effectively reduces gastric acid secretion. Its main industrial applications include the treatment and management of gastroesophageal reflux disease (GERD), erosive esophagitis, peptic ulcers, and the prevention of NSAID-associated gastric ulcers. It is also used to eradicate Helicobacter pylori infection in combination therapies and to manage pathological hypersecretory conditions like Zollinger-Ellison syndrome. Esomeprazole’s specific inhibitory action on the proton pump in stomach parietal cells makes it a preferred drug for acid-related disorders, providing superior acid control and improved clinical outcomes compared to omeprazole.
The major market drivers of esomeprazole include the rising prevalence of gastroesophageal reflux disease (GERD) and other acid-related disorders, and an ageing global population susceptible to these conditions. Factors such as increasing healthcare expenditure and growing awareness and diagnosis worldwide boost its market growth. Innovation in drug formulations, such as extended-release and improved delivery systems, and the expanding use of esomeprazole in Helicobacter pylori eradication therapies also support demand growth. The type of formulation (tablet, capsule, injectable), stability of the product, and packaging standards influence sourcing, especially to meet storage and transportation regulations.
Advanced formulations such as delayed-release or speciality delivery systems require sourcing from suppliers capable of producing these specialised forms with stringent specifications, which impact procurement. Increasing emphasis on sustainable sourcing, green chemistry practices, and environmental certifications influences esomeprazole procurement, especially in regions with strict environmental regulations.
Raw Material for Esomeprazole Production
According to the Esomeprazole production plant project report, the various raw materials for Esomeprazole production include 2-sulfhydryl-5-methoxybenzimidazole and 2-chloromethyl-3,5-dimethyl-4-methoxypyridine hydrochloride.
Production Process of Esomeprazole
The extensive Esomeprazole production cost report consists of the following major industrial production process:
- Production via condensation reaction: The industrial production process of esomeprazole sodium begins with the condensation of 2-sulfhydryl-5-methoxybenzimidazole and 2-chloromethyl-3,5-dimethyl-4-methoxypyridine hydrochloride in the presence of a phase-transfer catalyst and mineral alkali, producing omeprazole thioether. This intermediate is then subjected to a low-temperature asymmetric chiral oxidation using (S,S)-diethyl tartrate, titanium isopropoxide, N,N-diisopropylethylamine, and cumene hydroperoxide in toluene and water, which forms the chiral esomeprazole intermediate. Following oxidation, the mixture undergoes extraction, pH adjustment, and then salting by adding an alcoholic solution of sodium alkoxide (e.g., sodium hydroxide in acetonitrile), which induces crystallisation of esomeprazole sodium.
Properties of Esomeprazole
Esomeprazole is a chiral proton pump inhibitor with the molecular formula C17H19N3O3S and a molecular weight of 345.42 g/mol. It appears as a solid, crystalline powder that is thermodynamically stable. Its melting point ranges around 155-174 degree Celsius, depending on the form. Esomeprazole is very slightly soluble in water, with a solubility of 0.3 to 1.5 mg/mL at neutral to slightly basic pH (around pH 7 to 10). It has a logP value (octanol-water partition coefficient) ranging from about 0.6 to 2.4, indicating moderate lipophilicity.
The compound contains one chiral sulfur atom with the S-configuration. Its polar surface area is around 77-96 Ų, with 1 hydrogen bond donor and 5 hydrogen bond acceptors, and it has 5 rotatable bonds. Esomeprazole magnesium trihydrate is a commonly used salt form with a molecular weight of about 767.2 g/mol (including water of hydration). It is sensitive to air and heat, requiring storage under an inert atmosphere at low temperatures for stability. The compound is practically used in its salt forms, like sodium or magnesium salts, to enhance solubility and stability for pharmaceutical formulations.